[go: up one dir, main page]

WO2003057014A3 - Biomarqueurs destines a la detection du cancer de l'ovaire - Google Patents

Biomarqueurs destines a la detection du cancer de l'ovaire Download PDF

Info

Publication number
WO2003057014A3
WO2003057014A3 PCT/US2003/000531 US0300531W WO03057014A3 WO 2003057014 A3 WO2003057014 A3 WO 2003057014A3 US 0300531 W US0300531 W US 0300531W WO 03057014 A3 WO03057014 A3 WO 03057014A3
Authority
WO
WIPO (PCT)
Prior art keywords
ovarian cancer
biomarkers
detecting ovarian
subject
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/000531
Other languages
English (en)
Other versions
WO2003057014A9 (fr
WO2003057014A2 (fr
Inventor
Daniel W Chan
Zhen Zheng
Alex Jaideep Rai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Priority to US10/500,838 priority Critical patent/US20050214760A1/en
Priority to AU2003235749A priority patent/AU2003235749A1/en
Publication of WO2003057014A2 publication Critical patent/WO2003057014A2/fr
Publication of WO2003057014A9 publication Critical patent/WO2003057014A9/fr
Publication of WO2003057014A3 publication Critical patent/WO2003057014A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

L'invention concerne des nouveaux biomarqueurs destinés à la détection d'un cancer dans un prélèvement, en particulier du cancer de l'ovaire. Un aspect préféré de l'invention concerne des méthodes permettant d'évaluer le stade d'un cancer de l'ovaire chez un patient, consistant à mesurer au moins un des marqueurs I à VII dans un prélèvement, puis à comparer les mesures au stade du cancer de l'ovaire.
PCT/US2003/000531 2002-01-07 2003-01-07 Biomarqueurs destines a la detection du cancer de l'ovaire Ceased WO2003057014A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/500,838 US20050214760A1 (en) 2002-01-07 2003-01-07 Biomarkers for detecting ovarian cancer
AU2003235749A AU2003235749A1 (en) 2002-01-07 2003-01-07 Biomarkers for detecting ovarian cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34653602P 2002-01-07 2002-01-07
US60/346,536 2002-01-07

Publications (3)

Publication Number Publication Date
WO2003057014A2 WO2003057014A2 (fr) 2003-07-17
WO2003057014A9 WO2003057014A9 (fr) 2004-02-26
WO2003057014A3 true WO2003057014A3 (fr) 2004-05-13

Family

ID=23359856

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/000531 Ceased WO2003057014A2 (fr) 2002-01-07 2003-01-07 Biomarqueurs destines a la detection du cancer de l'ovaire

Country Status (2)

Country Link
AU (1) AU2003235749A1 (fr)
WO (1) WO2003057014A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4644123B2 (ja) 2002-08-06 2011-03-02 ザ・ジョンズ・ホプキンス・ユニバーシティ 卵巣がんを検出するためのバイオマーカーの使用
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
WO2005011474A2 (fr) * 2003-08-01 2005-02-10 Correlogic Systems, Inc. Multiples caracteristiques proteomiques de serums haute resolution pour la detection du cancer de l'ovaire
EP1668149A4 (fr) * 2003-09-05 2007-01-03 Royal Women S Hospital Marqueur pour le diagnostic du cancer de l'ovaire
AU2006223374B2 (en) * 2005-03-11 2011-07-21 Aspira Women’s Health Inc. Biomarkers for ovarian cancer and endometrial cancer: hepcidin
AU2015210343B2 (en) * 2005-06-24 2017-09-28 Aspira Women’s Health Inc. BIOMARKERS FOR OVARIAN CANCER: ß-2 MICROGLOBULIN
EP1910821B1 (fr) * 2005-06-24 2013-02-20 Ciphergen Biosystems, Inc. Biomarqueurs pour le cancer des ovaires
AU2012216473B2 (en) * 2005-06-24 2015-08-20 Aspira Women’s Health Inc. Biomarkers for ovarian cancer: beta-2 microglobulin
ATE503846T1 (de) 2005-09-15 2011-04-15 Val Chum S E C Verfahren zur diagnose eines ovarialkarzinoms
US7491504B2 (en) * 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
EP2220506B1 (fr) 2007-10-29 2013-10-02 Vermillion, Inc. Biomarqueurs permettant la détection du cancer des ovaires à un stade précoce
US8962257B2 (en) 2010-03-08 2015-02-24 The Trustees Of The University Of Pennsylvania Methods for diagnosing heart failure and other cardiac diseases
EP2683835B1 (fr) 2011-03-08 2017-01-11 King Abdullah University Of Science And Technology Biomarqueur moléculaire destiné à la détection précoce du cancer des ovaires
CA2829516C (fr) 2011-03-11 2020-08-18 Vib Vzw Molecules et procedes d'inhibition et de detection de proteines
WO2014152773A1 (fr) 2013-03-15 2014-09-25 The Trustees Of The University Of Pennsylvania Biomarqueurs sanguins prédisant la persistance d'un dysfonctionnement cognitif après commotion
AU2020326698A1 (en) 2019-08-05 2022-02-24 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650291A (en) * 1989-07-31 1997-07-22 The University Of British Columbia Monoclonal antibodies against an antigen associated with ovarian cervical and other tumors
US6511806B1 (en) * 1999-11-03 2003-01-28 Oncotech, Inc. Methods for cancer prognosis and diagnosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650291A (en) * 1989-07-31 1997-07-22 The University Of British Columbia Monoclonal antibodies against an antigen associated with ovarian cervical and other tumors
US6511806B1 (en) * 1999-11-03 2003-01-28 Oncotech, Inc. Methods for cancer prognosis and diagnosis

Also Published As

Publication number Publication date
WO2003057014A9 (fr) 2004-02-26
AU2003235749A1 (en) 2003-07-24
AU2003235749A8 (en) 2003-07-24
WO2003057014A2 (fr) 2003-07-17

Similar Documents

Publication Publication Date Title
WO2004013609A8 (fr) Utilisation de biomarqueurs pour detecter un cancer de l'ovaire
WO2003057014A3 (fr) Biomarqueurs destines a la detection du cancer de l'ovaire
WO2004099432A3 (fr) Identification de biomarqueurs permettant de detecter la presence d'un cancer du pancreas
WO2005098447A3 (fr) Biomarqueurs du cancer de l'ovaire
WO2004061410A3 (fr) Biomarqueurs seriques du cancer du poumon
EP1845363A3 (fr) Analyseur d'échantillon
TW200636245A (en) Colorimetric sensors constructed of diacetylene materials
AU2006316189A8 (en) Novel quantitative and qualitative analysis apparatus for measuring the body fluid
AU2003244342A1 (en) Biosensor, magnetic molecule measurement method, and measurement object measuring method
IL169103A0 (en) An analyte measuring system which prevents the reuse of a test strip
WO2004075713A3 (fr) Dosage a marqueurs multiples utilise pour depister un cancer des ovaires
WO2007140185A3 (fr) Procédés pour une mesure analytique non invasive
CA2701341A1 (fr) Procede de detection du cancer colorectal a partir d'un echantillon de selles au moyen d'une combinaison de marqueurs associant la calprotectine et le complexe hemoglobine/haptoglobine
WO2008048508A3 (fr) Biomarqueurs pronostiques chez des patientes souffrant d'un cancer des ovaires
WO2003091695A3 (fr) Identification de marqueurs biologiques pour la detection du cancer de la prostate
WO2004057336A3 (fr) Utilisation de la nicotinamide n-methyltransferase comme marqueur du cancer colorectal
AU2003229455A1 (en) Rapid vaccinia antibody detection device, method and test kit
WO2003076896A3 (fr) Utilisation de biomarqueurs pour detecter le cancer du sein
AU2001295649A1 (en) Method for performing chemical and isotopic analysis and measurements on constituents transported by a bore fluid
WO2007030949A3 (fr) Procedes de diagnostic de cancer des ovaires et necessaires a cet effet
WO2009082533A3 (fr) Procédé d'identification de composés pétroliers par mélange de fréquences sur des surfaces
TW200717291A (en) Methods and portable electronic apparatuses for application execution
WO2004097030A3 (fr) Biomarqueurs pronostiques du cancer du sein
WO2004071267A3 (fr) Diagnostic du cancer colono-rectal par detection de nicotinamide n-methyltransferase dans un echantillon de selles
WO2007105300A8 (fr) Dispositif et programme de communication sans fil et son procede de communication sans fil

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGES 50-60, CLAIMS, REPLACED BY NEW PAGES 50-59; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10500838

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP